ASCO 2024: Learn how precision medicine-specific LLMs can advance your oncology pipeline
At ASCO 2024, learn how Biomarker Intelligence can advance your precision oncology pipeline. Here’s a sneak peek at what you’ll experience when you demo QuartzBio’s AI-enabled Biomarker Intelligence Platform, powered by the first precision medicine-specific LLM ecosystem, at booth #15143. Read More →
AI-Enabled Biomarker Intelligence — QuartzBio at Bio-IT World 2024
Discussions were lively at the “Digitization of Clinical Development & Clinical Trials” symposium at last week’s Bio-IT World conference. Addressing an audience of biotech and pharma IT and data leaders, QuartzBio’s Tobi Guennel gave a provocative presentation on how deploying generative AI can amplify the ability of precision medicine approaches to accelerate drug development. Read More →
Key Takeaways: Biomarker Intelligence Summit, March 2024
Last week, biomarker intelligence leaders from Boston-area R&D organizations got a firsthand look at the powerful predictive and prescriptive intelligence that will soon infuse QuartzBio's AI Biomarker Intelligence Platform, after sharing common challenges facing data-rich precision medicine clinical programs. Read More →
Tell me what I don’t know: AI-enhanced decisions in biomarker-informed trials
Tobi Guennel, PhD, QuartzBio’s Senior Vice President of Product & Chief Architect, energized the Biomarkers & Precision Medicine track at SCOPE 2024 by showing how generative AI can address challenges faced biospecimen and biomarker operations teams, as well as clinical and translational teams, when gathering insights on samples across all parts of a complex biomarker data ecosystem. Read More →
